1 – 16 of 16
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Early appearance of thyroid autoimmunity in children followed from birth for type 1 diabetes risk
2024) In The Journal of clinical endocrinology and metabolism(
- Contribution to journal › Article
-
Mark
Vitamin D insufficiency in infants with increased risk of developing type 1 diabetes : A secondary analysis of the POInT Study
(
- Contribution to journal › Article
-
Mark
Infection episodes and islet autoantibodies in children at increased risk for type 1 diabetes before and during the COVID-19 pandemic
2024) In Infection(
- Contribution to journal › Article
-
Mark
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes
2024) In Diabetes Care(
- Contribution to journal › Article
-
Mark
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes
2024) In Diabetologia(
- Contribution to journal › Article
- 2023
-
Mark
SARS-CoV-2 - No Increased Islet Autoimmunity or Type 1 Diabetes in Teens
(
- Contribution to journal › Letter
-
Mark
Polymorphisms in Intron 1 of HLA-DRA Differentially Associate with Type 1 Diabetes and Celiac Disease and Implicate Involvement of Complement System Genes C4A and C4B
2023) In eLife(
- Contribution to journal › Article
-
Mark
SARS-CoV-2 Infection and Development of Islet Autoimmunity in Early Childhood
(
- Contribution to journal › Article
-
Mark
Interaction Between Dietary Iron Intake and Genetically Determined Iron Overload : Risk of Islet Autoimmunity and Progression to Type 1 Diabetes in the TEDDY Study
(
- Contribution to journal › Article
- 2022
-
Mark
HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children
(
- Contribution to journal › Article
-
Mark
The emotional well-being of parents with children at genetic risk for type 1 diabetes before and during participation in the POInT-study
(
- Contribution to journal › Article
-
Mark
Telomere length is not a main factor for the development of islet autoimmunity and type 1 diabetes in the TEDDY study
(
- Contribution to journal › Article
- 2021
-
Mark
An Age-Related Exponential Decline in the Risk of Multiple Islet Autoantibody Seroconversion During Childhood
(
- Contribution to journal › Article
-
Mark
Simplifying prediction of disease progression in pre-symptomatic type 1 diabetes using a single blood sample
(
- Contribution to journal › Article
-
Mark
Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes : Joint Analyses of Prospective Cohort Studies in Finland, Germany, Sweden, and the U.S
(
- Contribution to journal › Article
- 2019
-
Mark
Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk : The GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
(
- Contribution to journal › Article